TechnipFMC plc Ordinary Share vs uniQure N.V. Ordinary Shares — how do they compare? TechnipFMC plc Ordinary Share trades at $69.36 (market cap $27.26B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 18.8× uniQure N.V. Ordinary Shares's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| FTI | QURE | |
|---|---|---|
Market Cap | $27.26B | $1.45B |
Volume | 2,810,566 | 3,323,243 |
Sector | Energy | Health |
52-Week High | $80.08 | $70.59 |
52-Week Low | $35.57 | $9.03 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $27.51B | $707.46M |
Dividend Yield | 0.29% | — |
Signals from Pluang's Aura AI — not financial advice
FTI trades at $70.72, up 1.39% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with 36.04% ROE and 11.28% net margin. Recent Petrobras contract wins and strategic hires strengthen its subsea and consulting capabilities. Analyst consensus remains bullish with a $80.50 price target representing 14% upside potential.
FTI presents a compelling growth story with consistent earnings outperformance and strategic expansion, though technical indicators suggest near-term consolidation. The primary risk involves execution of recent contracts and maintaining profitability amid rising expenses. With zero sell ratings and institutional accumulation, the stock offers upside potential for investors comfortable with energy sector volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →